Cargando…

Declining Use of Corticosteroids for Crohn’s Disease Has Implications for Study Recruitment: Results of a Pilot Randomized Controlled Trial

BACKGROUND: Corticosteroids (CS) have been used extensively to induce remission in Crohn’s disease (CD); however, they are associated with severe side effects. We hypothesized that the administration of an exclusive enteral nutrition (EEN) formula to CS would lead to increased CD remission rates and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balart, M T, Russell, L, Narula, N, Bajaj, G, Chauhan, U, Khan, K J, Marwaha, A N, Ching, E, Biro, J, Halder, S, Tse, F, Marshall, J K, Collins, S M, Moayyedi, P, Bercik, P, Verdu, E F, Leontiadis, G I, Armstrong, D, Pinto-Sanchez, M I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489529/ https://www.ncbi.nlm.nih.gov/pubmed/34617003 http://dx.doi.org/10.1093/jcag/gwaa037

Ejemplares similares

Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease
por: Moayyedi, Paul, et al.
Publicado: (2019)

Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease
por: Moayyedi, Paul, et al.
Publicado: (2020)

A19 INVESTIGATING MECHANISMS THAT DRIVE SYMPTOMS IN IRRITABLE BOWEL SYNDROME PATIENTS WITH PERCEIVED GLUTEN SENSITIVITY
por: Seiler, C, et al.
Publicado: (2023)

A3 CROHN’S DISEASE PROTEOLYTIC MICROBIOTA ENHANCES INFLAMMATION THROUGH PAR2 PATHWAY IN GNOTOBIOTIC MICE
por: Hann, A, et al.
Publicado: (2023)

Canadian Association of Gastroenterology Statement on the Putative Link Between Proton Pump Inhibitor Treatment and Gastric Cancer after Helicobacter pylori Eradication
por: Leontiadis, Grigorios I, et al.
Publicado: (2018)

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease
por: Panaccione, Remo, et al.
Publicado: (2019)

Microbiota signatures and mucosal healing in the use of enteral nutrition therapy v. corticosteroids for the treatment of children with Crohn’s disease: a systematic review and meta-analysis
por: Ding, Zhaolu, et al.
Publicado: (2023)

COVID-19 Vaccination in Patients With Inflammatory Bowel Disease: Communiqué From the Canadian Association of Gastroenterology
por: Tse, Frances, et al.
Publicado: (2021)

A45 FIBER-FREE DIET REDUCES BACTEROIDES ABUNDANCE AND PREVENTS MUCUS DEGRADATION IN MICE COLONIZED WITH MICROBIOTA FROM PATIENTS WITH GENERALIZED ANXIETY DISORDER
por: Rabbia, V, et al.
Publicado: (2023)

A14 THE INTESTINAL MICROBIOTA CONTRIBUTES TO AGE-RELATED MEMORY DECLINE
por: Kraimi, N, et al.
Publicado: (2022)

A144 CHRONIC DSS LEADS TO ALTERED EXPRESSION OF IRAK4/TPL2 PATHWAYS IN UC-COLONIZED MICE
por: Hann, A, et al.
Publicado: (2022)

Altered colonic function and microbiota profile in a mouse model of chronic depression
por: Park, A J, et al.
Publicado: (2013)

COVID-19: Advice from the Canadian Association of Gastroenterology for Endoscopy Facilities, as of March 16, 2020
por: Tse, Frances, et al.
Publicado: (2020)

Patients’ Experiences and Challenges in Living with Inflammatory Bowel Disease: A Qualitative Approach
por: Popov, Jelena, et al.
Publicado: (2021)

Treatment of Isolated Gastric Crohn's Disease with Inhaled Corticosteroids
por: Ibrahim, Samar H., et al.
Publicado: (2008)

A236 ASSOCIATION OF STOOL METABOLOMIC PROFILE AND MICROBIOME COMPOSITION RISK SCORE WITH FUTURE ONSET OF CROHN’S DISEASE
por: Lee, S, et al.
Publicado: (2022)

A248 THE ROLE OF DIETARY TRYPTOPHAN IN INDOLE AND KYNURENINE PRODUCTION AND IMMUNE MODULATION IN HEALTHY INDIVIDUALS
por: Rueda, G H, et al.
Publicado: (2022)

A8 MICROBIAL ACTIVATION OF INTESTINAL DENDRITIC CELLS IS CRITICAL FOR THE ESTABLISHMENT OF NORMAL BEHAVIOR
por: Kraimi, N, et al.
Publicado: (2023)

Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn’s disease
por: Jongsma, Maria M. E., et al.
Publicado: (2022)

Adalimumab for the treatment of fistulas in patients with Crohn’s disease
por: Colombel, J-F, et al.
Publicado: (2009)

Crohn’s disease proteolytic microbiota enhances inflammation through PAR2 pathway in gnotobiotic mice
por: Santiago, Alba, et al.
Publicado: (2023)

A218 ASSOCIATIONS BETWEEN ADHERENCE TO LITERATURE-DERIVED DIETARY INDICES AND PRE-DISEASE BIOMARKERS: IMPLICATIONS FOR CROHN’S DISEASE PREVENTION
por: Neustaeter, A, et al.
Publicado: (2023)

Canadian Association of Gastroenterology (CAG) Position Statement on the Use of Hyoscine-n-butylbromide (Buscopan) During Gastrointestinal Endoscopy
por: Forbes, Nauzer, et al.
Publicado: (2021)

Nutritional profile of rodent diets impacts experimental reproducibility in microbiome preclinical research
por: Tuck, C. J., et al.
Publicado: (2020)

Acute Dermato-Lymphangio-Adenitis Following Administration of Infliximab for Crohn's Disease
por: Liyanage, I.K., et al.
Publicado: (2019)

A238 ALTERED GUT MICROBIOME COMPOSITION AND FUNCTION ARE ASSOCIATED WITH GUT BARRIER DYSFUNCTION IN HEALTHY RELATIVES OF CROHN’S DISEASE PATIENTS
por: Leibovitzh, H, et al.
Publicado: (2022)

Systematic review of surgical interventions for Crohn's anal fistula
por: Lee, M. J., et al.
Publicado: (2017)

Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn’s Disease
por: Mack, David R, et al.
Publicado: (2019)

A46 BIOGEOGRAPHIC VARIATION AND FUNCTIONAL PATHWAYS OF THE GUT MICROBIOTA IN CELIAC DISEASE
por: Libertucci, J, et al.
Publicado: (2022)

A238 BILE ACID COMPOSITION AND DIETARY FAT: IMPLICATIONS FOR CROHN’S DISEASE IN A COHORT OF HEALTHY FIRST-DEGREE RELATIVES
por: Neustaeter, A, et al.
Publicado: (2023)

Influence of previous corticosteroid treatment on the efficacy and safety of infliximab therapy in Crohn disease
por: Liu, Ailing, et al.
Publicado: (2019)

Misuse of Topical Corticosteroids for Cosmetic Purpose in Antananarivo, Madagascar
por: Sendrasoa, F. A., et al.
Publicado: (2017)

Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement
por: Drucker, A.M., et al.
Publicado: (2018)

Aspects Towards the Anastomotic Healing in Crohn’s Disease: Clinical Approach and Current Gaps in Research
por: Chaim, F.H.M., et al.
Publicado: (2022)

The Molecular Processes in the Trabecular Meshwork After Exposure to Corticosteroids and in Corticosteroid-Induced Ocular Hypertension
por: Liesenborghs, Ilona, et al.
Publicado: (2020)

Vedolizumab in Combination With Corticosteroids for Induction Therapy in Crohn’s Disease: A Post Hoc Analysis of GEMINI 2 and 3
por: Sands, Bruce E, et al.
Publicado: (2019)

Psychiatric Adverse Effects of treatement with Corticosteroids: A Tunisian case report
por: Boussaid, N., et al.
Publicado: (2023)

A116 OPTIMIZING CROHN’S DISEASE ENDOSCOPIC SCORING OPERATING CHARACTERISTICS TO ASSIST WITH THE ADVENT OF ARTIFICIAL INTELLIGENCE
por: Galts, C, et al.
Publicado: (2023)

Corticosteroids for critically ill patients: an international survey of intensivists
por: Lamontagne, F, et al.
Publicado: (2012)

17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use
por: Farzan, N., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2ngo1vvvvdg52n9tjqteaqdsih